Protara Therapeutics, Inc. (TARA) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$23.32M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$19.63M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$14.76M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$16.59M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2012-12-31 to 2017-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$23.32M | (m) | (m) | (m) | (m) | -$15.39M* | (m) | $16.95M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$19.63M | (m) | (m) | (m) | (m) | -$21.34M | (m) | $13.56M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$14.76M | (m) | (m) | (m) | $4.00K* | -$12.45M* | (m) | $9.59M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$16.59M | (m) | (m) | (m) | $22.00K* | -$12.25M* | (m) | $10.77M | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$14.12M | (m) | (m) | (m) | $44.00K | -$14.71M | (m) | $9.15M | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$12.33M | (m) | (m) | (m) | $8.00K* | -$8.43M* | (m) | $8.07M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$10.66M | (m) | (m) | (m) | (m) | -$7.69M* | (m) | $6.39M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$11.85M | (m) | (m) | (m) | (m) | -$10.38M | (m) | $7.75M | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$10.70M | (m) | (m) | (m) | $37.00K* | -$6.56M* | (m) | $6.22M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$12.14M | (m) | (m) | (m) | $2.00K* | -$9.41M* | (m) | $7.25M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$9.73M | (m) | (m) | (m) | $6.00K | -$12.89M | (m) | $5.14M | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$7.97M | (m) | (m) | (m) | $83.00K* | -$5.35M* | (m) | $3.47M | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$8.71M | (m) | (m) | (m) | $20.00K* | -$5.12M* | (m) | $3.08M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$10.87M | (m) | (m) | (m) | $11.00K | -$10.96M | (m) | $5.27M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$10.83M | (m) | (m) | (m) | -$64.00K* | -$6.20M* | (m) | $4.09M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$12.79M | (m) | (m) | (m) | $326.00K* | -$9.47M* | (m) | $5.89M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$13.58M | (m) | (m) | (m) | $290.00K | -$11.92M | (m) | $7.04M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$8.06M | (m) | (m) | (m) | $132.00K* | -$3.76M* | (m) | $2.80M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$7.27M | (m) | (m) | (m) | -$6.00K* | -$5.73M* | (m) | $2.47M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$10.16M | (m) | (m) | (m) | $247.00K | -$7.15M | (m) | $3.06M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$2.35M | (m) | (m) | (m) | $325.40K* | -$1.21M* | (m) | $1.10M | (m) | $0.00* |
|---|
| 2019-06-30 | Reported | (m) | -$1.43M | (m) | (m) | (m) | $76.63K* | -$1.30M* | (m) | $986.72K | (m) | $0.00* |
|---|
| 2019-03-31 | Reported | (m) | -$1.53M | (m) | (m) | (m) | $27.11K | -$1.41M | (m) | $1.08M | (m) | $0.00 |
|---|
| 2018-09-30 | Reported | (m) | -$4.62M | (m) | (m) | (m) | $3.00K* | -$3.12M* | (m) | $2.35M | (m) | $0.00* |
|---|
| 2018-06-30 | Reported | (m) | -$5.00M | (m) | (m) | (m) | $12.00K* | -$10.35M* | (m) | $2.76M | (m) | $0.00* |
|---|
| 2018-03-31 | Reported | (m) | -$6.37M | (m) | (m) | (m) | $9.00K | -$5.46M | (m) | $4.07M | (m) | $0.00 |
|---|
| 2017-09-30 | Reported | -$12.27M* | -$12.31M | $38.00K* | (m) | (m) | $9.00K* | -$5.93M* | (m) | $10.34M | (m) | $0.00* |
|---|
| 2017-06-30 | Reported | -$5.95M* | -$5.99M | $37.00K* | (m) | (m) | $8.00K* | -$3.28M* | (m) | $3.89M | (m) | $0.00* |
|---|
| 2017-03-31 | Reported | -$6.44M | (m) | (m) | (m) | (m) | $6.00K | -$7.45M | (m) | $4.25M | (m) | $0.00 |
|---|
| 2016-12-31 | Reported | -$6.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2016-09-30 | Reported | -$7.13M* | -$7.17M | $35.00K* | (m) | (m) | $57.00K* | (m) | (m) | $4.84M | (m) | $0.00* |
|---|
| 2016-06-30 | Reported | -$7.83M* | -$7.85M | $28.00K* | (m) | (m) | $194.00K* | (m) | (m) | $5.24M | (m) | $0.00* |
|---|
| 2016-03-31 | Reported | -$6.8M | (m) | (m) | (m) | (m) | $8.00K | (m) | (m) | $4.35M | (m) | $0.00 |
|---|
| 2015-12-31 | Reported | -$6.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2015-09-30 | Reported | -$5.07M* | -$5.08M | $16.00K* | (m) | (m) | $135.00K* | (m) | (m) | $3.08M | (m) | $0.00 |
|---|
| 2015-06-30 | Reported | -$4.97M* | -$4.98M | $9.00K* | (m) | (m) | $31.00K* | (m) | (m) | $3.09M | (m) | $0.00 |
|---|
| 2015-03-31 | Reported | -$4.61M | (m) | (m) | (m) | (m) | $5.00K | (m) | (m) | $2.63M | (m) | $0.00 |
|---|
| 2014-12-31 | Reported | -$3.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2014-09-30 | Reported | $142.00K* | $134.00K | $8.00K* | (m) | (m) | $9.00K* | (m) | (m) | $1.77M | (m) | $0.00 |
|---|
| 2014-06-30 | Reported | -$2.50M* | -$2.51M | $6.00K* | (m) | (m) | (m) | (m) | (m) | $1.60M | (m) | $0.00 |
|---|
| 2014-03-31 | Reported | -$1.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.19M | (m) | $0.00 |
|---|
| 2013-12-31 | Reported | -$1.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2013-09-30 | Reported | (m) | -$1.91M | (m) | (m) | (m) | (m) | (m) | (m) | $971.00K | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$64.55M | (m) | (m) | (m) | $94.00K | -$56.37M | (m) | $42.63M | (m) | (m) |
|---|
| 2024-12-31 | Reported | (m) | -$49.15M | (m) | (m) | (m) | $63.00K | -$35.81M | (m) | $31.70M | (m) | (m) |
|---|
| 2023-12-31 | Reported | (m) | -$43.61M | (m) | (m) | (m) | $45.00K | -$37.56M | (m) | $24.99M | (m) | (m) |
|---|
| 2022-12-31 | Reported | (m) | -$67.06M | (m) | (m) | (m) | $120.00K | -$26.46M | (m) | $16.81M | (m) | (m) |
|---|
| 2021-12-31 | Reported | (m) | -$47.49M | (m) | (m) | (m) | $596.00K | -$34.50M | (m) | $21.09M | (m) | (m) |
|---|
| 2020-12-31 | Reported | (m) | -$34.44M | (m) | (m) | (m) | $884.00K | -$23.41M | (m) | $11.98M | (m) | (m) |
|---|
| 2019-12-31 | Reported | (m) | -$7.83M | (m) | (m) | (m) | $475.00K | -$5.01M | (m) | $3.88M | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$21.37M | (m) | (m) | (m) | $119.00K | -$23.23M | (m) | $11.85M | (m) | (m) |
|---|
| 2017-12-31 | Reported | (m) | -$30.36M | (m) | (m) | (m) | $35.00K | -$22.35M | (m) | $21.69M | (m) | (m) |
|---|
| 2016-12-31 | Reported | -$28.58M | (m) | (m) | (m) | (m) | $271.00K | -$23.69M | (m) | $18.87M | (m) | (m) |
|---|
| 2015-12-31 | Reported | -$20.81M | (m) | (m) | (m) | (m) | $198.00K | -$17.57M | (m) | $12.38M | (m) | (m) |
|---|
| 2014-12-31 | Reported | -$7.55M | (m) | (m) | (m) | -256.11% | $51.00K | (m) | (m) | $6.43M | (m) | -$110.00K |
|---|
| 2013-12-31 | Reported | -$7.1M | (m) | (m) | (m) | (m) | $10.00K | (m) | (m) | $3.99M | (m) | $92.00K |
|---|
| 2012-12-31 | Reported | -$7.94M | (m) | (m) | (m) | (m) | $67.00K | (m) | (m) | $5.91M | (m) | -$140.00K |
|---|